Diabetes

News

All

Transfer

Public Engagement

Awards & Grants

Diabetes

Stem Cells

Environmental Health

Computational Health

Bioengeineering

Molecular Targets & Therapeutics

Pioneer Campus

Schwangere Frau mit Ultraschallbildern

New Research Findings, Diabetes, IDF,

Maternal Type 1 Diabetes May Protect Children Through Epigenetic Changes

Children with a family history of type 1 diabetes (T1D) have an increased risk of developing the disease. However, children born to mothers with T1D are less likely to develop the disease than those whose fathers or siblings have T1D. A new study…

HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, IDR,

Comparing Pancreas Development Across Species to Advance Translational Research and Diabetes Therapies

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team headed by Helmholtz Munich and the German Center for Diabetes Research (DZD) has now produced a comprehensive evolutionary…

HMGU_Icon_Diabetes_2

Featured Publication, Diabetes, HI-MAG,

Salivary Extracellular Vesicle-Derived microRNAs Are Linked to Obesity, Taste, and Eating Behavior

A research team at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), an institute from Helmholtz Munich at the University of Leipzig and the University of Leipzig Medical Center, has identified that microRNAs derived from…

Brain illustration depicting addiction with clouds of junk food floating in a clear sky

IDM,

Obesity in the brain

Eating too many sweets or fatty foods alters the brain's hunger regulation after just a few days.

20251022_HHDC Cure Gala_092

Awards & Grants, Diabetes, IDF,

Anette-Gabriele Ziegler Receives Hamm International Prize for Diabetes Research

Prof. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute for Diabetes Research, is awarded with this year’s Hamm International Prize. She is being honored for her research to understand the pathogenesis of type 1 diabetes and efforts…

Ozempic and Wegovy semaglutide pens with pink tape measure

IDM,

Obesity therapy: Is concomitant administration of anabolic agents and related compounds warranted during GLP-1 receptor agonist treatment?

The October 3, 2025, issue of Deutsches Ärzteblatt discussed whether GLP-1 receptor agonists, which have proven to be extremely effective in weight loss, are associated with increased muscle loss - and whether complementary therapies are therefore…

Press Contact

COMS Communications & Strategic Relations
COMS Communications & Strategic Relations

+49 89 3187 49342

pressespam prevention@helmholtz-muenchen.de

Ingolstädter Landstr. 1